Cardiovascular
Acacia Subsidiary Acquires Patents for Catheter Ablation Technology
January 23, 2012 5:37 am | News | CommentsNEWPORT BEACH, Calif.--(BUSINESS WIRE)--Acacia Research Corporation announced today that a subsidiary has acquired patents relating to catheter ablation technology. “Acacia continues to increase the number of patent portfolios we control in the medical technology sector,†commented Paul Ryan...
Nanomedical Global Sales to Reach $130.9 Billion in 2016
January 23, 2012 5:24 am | News | CommentsWellesley, Mass. – According to a new technical market research report, NANOTECHNOLOGY IN MEDICAL APPLICATIONS: THE GLOBAL MARKET (HLC069B) from BCC Research, nanomedical global sales totaled $72.8 billion in 2011 and are expected to increase...
Crux Biomedical's IVC Filter Receives CE Mark Approval
January 23, 2012 5:05 am | News | CommentsMENLO PARK, Calif. /PRNewswire/ --Â Crux Biomedical announced it has received CE mark approval for their revolutionary inferior vena cava filter (IVCF) with bi-directional retrieval (BDR). Vena cava filters are designed to trap blood clots that can lead to a potentially fatal pulmonary embolism (PE).Â
Saint Thomas Heart Opens New Ventricular Assist Device Center; One of Only 33 Dedicated Centers in United States
January 20, 2012 5:23 am | News | CommentsNASHVILLE, Tenn.--(BUSINESS WIRE)--Saint Thomas Hospital, a member of Saint Thomas Health and a national leader in cardiac care, announced today the opening of the Saint Thomas Heart Ventricular Assist Device (VAD) Center at an invitation only event at LP Field.
Covidien Provides Update on Voluntary Recall of BIS Bilateral Sensors
January 20, 2012 5:10 am | News | CommentsBOULDER, Colo.--(BUSINESS WIRE)--On November 8, 2011, Covidien initiated a voluntary recall of certain lots of its BISâ„¢ Bilateral Sensors, due to a modification which inadvertently reversed the reference and left eye electrode. This modification could potentially cause a change...
European Coronary Stent Market to Decline to $490 Million by 2016, Despite Growth in Number of Procedures
January 20, 2012 5:06 am | News | CommentsTORONTO--(BUSINESS WIRE)--According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, while the number of coronary stenting procedures performed will show steady growth, stent selling prices will decline significantly...
Gore Receives First FDA Approval for Endovascular Repair of Traumatic Aortic Transections
January 20, 2012 5:01 am | News | CommentsFLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) announced that the US Food and Drug Administration (FDA) has approved the Conformable GORE® TAG® Thoracic Endoprosthesis for endovascular repair of isolated lesions of the descending thoracic aorta...
Indiana's medical device industry is fifth largest in U.S. generating $10 billion annually
January 20, 2012 4:41 am | News | CommentsINDIANAPOLIS, Ind., -Â According to a report released today by BioCrossroads, the medical devices industry is one of Indiana's most valuable economic assets employing over 20,000 people, and generating more than $10 billion of annual economic output. The first of its kind report...
Independent Data Safety Monitoring Board Recommends St. Jude Medical's FAME II Clinical Trial Stop Enrollment Following Positive Interim Analysis
January 19, 2012 5:13 am | News | CommentsST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, announced today that an interim analysis of the FAME II trial has found a highly statistically significant reduction in the need for hospital readmission and urgent revascularization when...
Slovenia's 1st Total Artificial Heart Patient Discharged from UMC Ljubljana Using the Freedom Portable Driver
January 19, 2012 4:55 am | News | CommentsTUCSON, Ariz. – SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced today that on Dec. 29, 2011, University Medical Center (UMC) Ljubljana discharged Slovenia's first Total Artificial Heart patient, 61-year-old...
Patients Report Controversial Multiple Sclerosis Treatment Improves Their Lives: Presented at ISET 2012
January 18, 2012 5:55 am | News | CommentsMIAMI BEACH, Fla.--(BUSINESS WIRE)--Although using angioplasty to treat multiple sclerosis (MS) is highly controversial, sufferers often insist it helps – in some cases dramatically, such as allowing them to walk without a cane. Patients with less severe MS also reported additional quality...
US BioDesign Launches Cardiovascular Biomaterials Business Segment
January 18, 2012 5:26 am | News | CommentsPERKASIE, Pa.--(BUSINESS WIRE)--US BioDesign announced today the launch of its cardiovascular biomaterials business segment. This portion of US BioDesign will be responsible for the research, analysis and production of products and services in the cardiovascular device area.
Medtronic Endurant II AAA Stent Graft System Launches Internationally with CE Mark
January 18, 2012 4:46 am | News | CommentsMINNEAPOLIS –– Medtronic Inc. today announced the CE (Conformité Européenne) mark and international launch of the Endurant® II AAA Stent Graft System, which meaningfully expands the options physicians outside the United States have to treat patients with abdominal aortic aneurysms...
Study Finds Intraosseous Infusion is Equivalent to Intravenous Infusion During Therapeutic Hypothermia
January 17, 2012 4:51 am | News | CommentsSAN ANTONIO--(BUSINESS WIRE)--The results of a study conducted by Vidacare Corporation comparing whether Intraosseous (IO) vascular access may be used to infuse chilled saline as effectively as peripheral intravenous (IV) access to achieve therapeutic hypothermia found no statistical...
Saudi Arabia Uses ZOLL's Temperature Management Solution to Revive Pilgrims from Heat Stroke During the Hajj Pilgrimage
January 16, 2012 5:34 am | News | CommentsCHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL® Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that the Saudi Arabia Ministry of Health purchased six ZOLL intravascular temperature management (IVTM™) systems...
Humedica Releases Cutting-Edge Predictive Model to Help Prevent Congestive Heart Failure Hospitalizations
January 16, 2012 5:15 am | News | CommentsBOSTON--(BUSINESS WIRE)--Humedica, the leading clinical analytics company, today announced the launch of a new predictive analytic model that will identify patients at high-risk for a Congestive Heart Failure (CHF) hospitalization. Designed to enable providers to identify high-risk CHF patients...
Data from St. Jude Medical's ASSERT Implantable Device Monitoring Study Published in New England Journal of Medicine
January 13, 2012 5:26 am | News | CommentsST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, a global medical device company, today announced the publication of results from the ASSERT cohort study in the New England Journal of Medicine (NEJM). The ASSERT study, or ASymptomatic AF and Stroke Evaluation...
Endosense Launches TactiCath 75 Force-Sensing Catheter, Announces New Results of EFFICAS I Clinical Study
January 13, 2012 5:14 am | News | CommentsGENEVA--(BUSINESS WIRE)--Endosense, a pioneer and leader in force-sensing technology focused on improving the efficacy and safety of catheter ablation for the treatment of cardiac arrhythmias, has announced the European launch of the TactiCath 75 force-sensing ablation catheter...
Biosense Webster Completes Enrollment in Ground-Breaking SMART-AF Trial
January 13, 2012 5:05 am | News | CommentsDIAMOND BAR, Calif.--(BUSINESS WIRE)--Biosense Webster Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced the completion of enrollment in their latest ground-breaking clinical trial, the SMART-AF Investigational Device Exemption (IDE) study.
Biosense Webster Announces FDA approval of the THERMOCOOL SF Catheter in the United States
January 13, 2012 5:03 am | News | CommentsDIAMOND BAR, Calif.--(BUSINESS WIRE)--Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced the FDA approval of the new THERMOCOOL® SF irrigated ablation catheter in the United States. The THERMOCOOL® SF NAV Catheter...
Intellicell Biosciences announces the licensing of its proprietary patent, pending stromal vascular fraction manufacturing technology
January 11, 2012 4:52 am | News | CommentsNEW YORK--(BUSINESS WIRE)--Intellicell Biosciences, Inc., (“Intellicellâ€) or the (“Companyâ€), has licensed its proprietary, patent, pending technology for the manufacture of stromal vascular fraction from adipose tissue to Cell-Innovations, Pty Limited a company headquartered...
Cameron Health Submits PMA Application to FDA for the S-ICD System
January 10, 2012 6:33 am | News | CommentsSAN CLEMENTE, Calif.--(BUSINESS WIRE)--Cameron Health, Inc. (“Cameron Healthâ€) announced today that it has submitted the Premarket Approval (PMA) application to the Food and Drug Administration (FDA) for the S-ICD System, the world's only completely subcutaneous implantable defibrillator.
US Interventional Cardiology Device Market Will Shrink by Three Percent Per Year Through 2016
January 10, 2012 6:19 am | News | CommentsTORONTO--(BUSINESS WIRE)--According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, interventional cardiology devices in the United States will see a shrinking overall market due to a maturity in procedures and heavy downward pressures...
MedPlast's Pessary Balloon Manufacture Showcases Multi-Function Technical Mastery(2)
January 10, 2012 6:09 am | News | CommentsELKHORN, Wis. -- MedPlast, Inc.'s ability to craft the pessary balloons that enhance quality of life for many women underscores the company's commitment to premium quality output and complete mastery of many separate - and complex - processes. Today's pessaries are precision-manufactured...
SANUWAVE Issued U.S. Patent for the Application of Acoustic Shock Waves Utilizing Its PACE Devices
January 9, 2012 5:48 am | News | CommentsALPHARETTA, Ga.--(BUSINESS WIRE)--SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today announced that the U.S. Patent and Trademark Office...
